Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability

French, 2003, Dose–response trial of pregabalin adjunctive therapy in patients with partial seizures, Neurology, 60, 1631, 10.1212/01.WNL.0000068024.20285.65 Arroyo, 2004, Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose–response study in adults with partial seizures, Epilepsia, 45, 20, 10.1111/j.0013-9580.2004.31203.x Beydoun, 2005, Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy, Neurology, 64, 475, 10.1212/01.WNL.0000150932.48688.BE Linden, 1994, Leitlinien zur Durchführung von Anwendungsbeobachtungen in der Psychopharmakatherapie, Der Nervenarzt, 65, 638 Association for Methodology and Documentation in Psychiatry (AMDP), Collegium Internationale Psychiatriae Scalarum (CIPS). Rating scales for psychiatry. European ed. Weinheim: Beltz Test GmbH; 1990. Engel, 2001, A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology, Epilepsia, 42, 796, 10.1046/j.1528-1157.2001.10401.x Carreňo, 2007, Pregabalin as add-on therapy for refractory partial seizures in everyday clinical practice, Seizure, 16, 709, 10.1016/j.seizure.2007.05.011 Simister, 2007, Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability, Epilepsy Behav, 10, 336, 10.1016/j.yebeh.2006.12.005 Huber, 1998, Lamotrigine in multihandicapped therapy-resistant epileptic patients, Clin Drug Invest, 16, 263, 10.2165/00044011-199816040-00001 Huber, 2002, [Effects of topiramate in patients with epilepsy and intellectual deficits], Nervenarzt, 73, 525, 10.1007/s00115-002-1294-3 Huber, 2003, Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients, Seizure, 12, 602, 10.1016/S1059-1311(03)00101-8 Huber, 2004, Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities, Seizure, 13, 168, 10.1016/S1059-1311(03)00154-7